中銀保監擬規範保險公司健康管理服務 要求合理定價
據《上海證券報》獨家獲悉,為進一步落實《健康保險管理辦法》有關要求,規範保險公司健康管理服務行為,切實提升專業化服務水平,促進商業健康保險穩健發展,中國銀保監會人身險部已起草《關於規範保險公司健康管理服務的通知(徵求意見稿)》,目前正在行業內部徵求意見。
徵求意見稿明確保險公司健康管理服務的定義和服務要求。在合理定價方面,徵求意見稿也予以明確規定:保險公司提供的健康管理服務包含在保險產品責任條款中的,其分攤成本不得超過淨保險費的20%,並應在條款中明確健康管理服務的具體內容,同時在精算報告中說明其定價依據。單獨提供健康管理服務的,應簽訂健康管理服務合同,並明確註明服務內容和服務價格。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.